1 Intensive Care Unit and Department of Anesthesiology, Institut Paoli-Calmettes, Marseille, France. 2 Department of Anesthesiology and Intensive Care, Hôpital Nord, Marseille, France. 3 Department of Surgery, Institut Paoli-Calmettes, Marseille, France
* Corresponding author. E-mail: mokartd{at}marseille.fnclcc.fr
Accepted for publication September 13, 2005.
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Methods. We designed a prospective cohort study of 93 adult patients undergoing major oncological surgery to identify the predictive risk factors for developing postoperative severe sepsis.
Results. Nineteen of 93 patients developed a severe sepsis after surgery; seven of the septic patients died in intensive care unit. Multivariate analysis discriminated preoperative and postoperative (first and second day after surgery) predictive risk factors. The postoperative severe sepsis was independently associated with preoperative factors like male gender (OR 4.7, 95% CI between 1.5 and 15.5, P<0.01) and Charlson co-morbidity index (OR 1.3, 95% CI between 1.07 and 1.6, P<0.01). After the surgery, the presence of systemic inflammatory response syndrome (OR 4.0, 95% CI between 1.02 and 15.7, P<0.05) and a logistic organ dysfunction score on day 2 (OR 3.3, 95% CI between 1.9 and 5.7, P<0.001) were found as independent predictive factors.
Conclusion. We have shown that some of the markers that can be easily collected in the preoperative or postoperative visits can be used to screen the patients at high risk for developing severe sepsis after major surgery.
Keywords: complications, postoperative sepsis ; sepsis, predictors ; surgery, major, cancer
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In the present study, our aim was to determine early predictive significant and independent risk factors for developing severe sepsis in patients undergoing major oncological surgery. These factors were collected at the preoperative consultation, and during the early postoperative period.
![]() |
Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
All data were collected during the intra-operative period (day 0) and on days 1 and 2 after surgery. Haemodynamic variables were electronically recorded preoperatively and at 5-min intervals throughout the surgery. Intra-operative systolic hypotension was defined as systolic arterial pressure below 80 mm Hg lasting for at least 5 min. The Charlson co-morbidity index,10 Karnofsky performance status,15 ASA physical status,11 Acute Physiology and Chronic Health Evaluation (APACHE II),16 Simplified Acute Physiology Score (SAPS II),17 and LOD score12 were measured everyday at the bedside by the same physician (D.M.). These scores were chosen because they are easy to determine at the bedside, or require only basic biological values. Intensive care unit physicians met every week to complete the data of patients who were discharged from the ICU, and then, to check the scores that were determined during the daily rounds. The Charlson co-morbidity index was originally designed to quantify underlying diseases and to classify prognostic co-morbidity, and can be divided into four co-morbidity grades (Table 1). The Karnofsky performance status allows patients to be classified according to their functional impairment. It is an attempt to measure the more subjective side of the outcome of cancer treatment. The LOD score was derived from a multiple logistic regression model with physiological variables defining the dysfunction in six organ systems. The data required to evaluate the Charlson co-morbidity index, Karnofsky score, ASA physical status, APACHE II, SAPS II, and LOD score were recorded preoperatively and then during the first 2 days after surgery. The occurrence of septic events was recorded postoperatively until day 10.
|
Statistical analysis
Categorical data are presented as number (%). Quantitative data are presented as mean (SD). Statistical analysis was performed using SPSS software (version 12.0; SPSS Inc., Chicago, IL). Univariate analysis was conducted to determine potential risk factors for the occurrence of severe sepsis. 2 tests or Fisher's exact tests were used for qualitative variables. The required significance level was set at a P<0.05. A multivariate analysis was used to quantify the respective role of each variable on the occurrence of severe sepsis. A stepwise logistic regression was performed (Backward method, likehood ratio). The explanatory variables included in the logistic regression were the variables identified as potential risk factors by the univariate analysis (cut-off P<0.2). The condensed model was presented with crude odds ratio (OR) and 95% confidence interval (CI), the required significance level was set at P<0.05. Discrimination was assessed using the area under the receiver operating characteristic curve to evaluate how well the model distinguished patients with severe sepsis from controls.
Preliminary data showed that 20% of cancer patients undergoing major surgery developed postoperative sepsis. To provide 80% power to detect an increase of 1.0 point of the LOD score between the septic group and the control group (=0.05), we needed to enroll at least 19 septic patients.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The univariate analysis showed that male gender, Charlson co-morbidity index and ASA more than II (all preoperative factors) were significantly associated with postoperative severe sepsis (Table 2). The multivariate analysis showed that male gender (OR 4.7, 95% CI between 1.5 and 15.5, P<0.01) and Charlson co-morbidity index (OR 1.3, 95% CI between 1.07 and 1.6, P<0.01) were independently associated with postoperative severe sepsis.
|
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In agreement with previous reports, our study suggests that male gender increases the risk for developing sepsis.6 After experimental trauma-haemorrhage, pre-treatment of female mice with testosterone depressed macrophage function, whereas blockade of testosterone receptors in males restored the depressed immune function.19 Estradiol appears to reduce the inflammatory response, as well as the lower expression of the disease in female than in male in regard to a similar exposition to a pathogen.20 Epidemiology of severe sepsis shows that women have lower age-adjusted severe sepsis rate.1 In addition, female gender has been associated with a decreased risk of severe sepsis in trauma patients.21 However, the exact cause for this gender difference in development of sepsis is unclear.
Our findings in the present study are in agreement with the previously demonstrated correlation between the Charlson co-morbidity index and the secretion of anti-inflammatory cytokines, which were responsible for postoperative immunosuppression in cancer surgical patients.22 In practice, a Charlson co-morbidity index of 6 or more during the preoperative visit can predict a risk for developing postoperative severe sepsis with an acceptable sensitivity. Although the ASA physical status is widely used to assess co-morbidity in high-risk surgical patients, a generally accepted co-morbidity measure is still lacking. We observed that the Charlson co-morbidity index is an interesting tool for the preoperative identification of high-risk surgical patients.10 In this index, co-morbid variables like metastatic cancer are weighted heavily. These variables may affect the development of postoperative sepsis. Hence, preoperatively, the ASA score and Karnofsky performance status, which are highly subjective, are ruled out from the multivariate analysis by the Charlson index. This finding underscores the need to implement a strategy for the reduction of perioperative risk to these patients.
We found that the early presence of SIRS after surgery was predictive of the development of severe sepsis. The quantification of SIRS is potentially overly sensitive in surgical populations. Surgical stress, anaesthesia, and postoperative pain can result in a systemic response that can mimic acute inflammation. However, an elevated SIRS score obtained between 24 and 48 h after admission, despite aggressive resuscitation, predicted an increased mortality,23 and persistent elevated SIRS score is predictive for nosocomial sepsis in trauma patients.24 On the other hand, patients recovering from early postoperative SIRS have lower incidence of multiple organ dysfunction than those with a persisting SIRS.9 In our study, SIRS score was determined only on day 2, minimizing the effect of surgical stress and pain.
We found that the LOD score is a good predictor for the postoperative severe sepsis. The LOD score was derived from a multiple logistic regression model with physiological variables defining the dysfunction in six organ systems. Daily LOD characterized the progression of multiple organ dysfunction during the first ICU week, and showed a good internal consistency.25 Moreover, the LOD score is as effective as sequential organ failure assessment score.25 In another study, the LOD score assessed before the diagnosis of catheter-related bacteraemia was associated with ICU mortality.26 In our study, 36% of the patients with severe sepsis did not survive, which is in agreement with previous data.18 27 Six patients died with criteria of SIRS and a LOD system greater than 0 on day 2 (data not shown). In fact, a LOD score of 1 or more is predictive for developing severe sepsis with a sensitivity of 80% and a specificity of 72%. The LOD is a better predictor than the APACHE II and SAPS II, which were designed to assess patients on their admission in ICU. The daily postoperative follow-up is a key point to determine the development of dysfunction of organs. We hypothesize that an early detection of these dysfunctions associated with an aggressive management, as described elsewhere,28 29 can reduce the ICU duration of stay and subsequently the mortality.
Our study has several limitations. First, only 93 cancer patients were studied of whom 19 developed severe sepsis, which is not enough to develop a predictive scoring system. Hence, further large studies are required to validate our findings. Secondly, our rate of severe sepsis (20%) can seem large following elective surgery, but it is in agreement with the findings of previous studies in cancer as well as non-cancer patients.13 30 Unfortunately, to our knowledge, the severe sepsis rate of cancer patients following major surgery has never been compared with that of non-cancer patients. The other limitation of this study is that few patients were treated with beta-blockers that could affect heart rate and SIRS diagnosis. However, these patients are not excluded from most studies, because they represent the real life conditions.
In conclusion, our study suggests that an early identification of patients at high risk of developing postoperative severe sepsis can be done with the use of easy-to-collect markers. The first step of this identification consists of the preoperative determination of the Charlson co-morbidity index. Next, the daily examination of patients must determine the criteria of SIRS and organ dysfunctions with the LOD score. This examination discriminates at the bedside the patients developing sepsis. These three markers represent an inexpensive way to detect the high-risk patients in whom an early aggressive goal therapy may be evaluated in future studies.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
2 Lobo SM, Salgado PF, Castillo VG, et al. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 2000; 28: 3396404[CrossRef][ISI][Medline]
3 Squadrone V, Coha M, Cerutti E, et al. Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. J Am Med Assoc 2005; 293: 58995
4 Faist E, Wichmann M, Kim C. Immunosuppression and immunomodulation in surgical patients. Curr Opin Crit Care 1997; 3: 29398
5 Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000; 85: 10917
6 Angele MK, Schwacha MG, Ayala A, Chaudry IH. Effect of gender and sex hormones on immune responses following shock. Shock 2000; 14: 8190[ISI][Medline]
7 Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 13850
8 Mokart D, Merlin M, Sannini A, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005; 94: 76773
9 Talmor M, Hydo L, Barie PS. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg 1999; 134: 817
10 Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 2005; 100: 410
11 Keats AS. The ASA classification of physical status a recapitulation. Anesthesiology 1978; 49: 2336[ISI][Medline]
12 Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. J Am Med Assoc 1996; 276: 80210[Abstract]
13 Velasco E, Thuler LC, Martins CA, Dias LM, Conalves VM. Risk factors for infectious complications after abdominal surgery for malignant disease. Am J Infect Control 1996; 24: 16[CrossRef][ISI][Medline]
14 Martin C, Viviand X, Gouin F. Pratique de l'antibioprohylaxie en chirurgie. Encycl Med Chir Anesthésie-Réanimation 1999; 36984-A-05: 12p
15 Liem BJ, Holland JM, Kang MY, Hoffelt SC, Marquez CM. Karnofsky Performance Status Assessment: resident versus attending. J Cancer Educ 2002; 17: 13841[ISI][Medline]
16 Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 25: 81829
17 Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 1993; 270: 295763[Abstract]
18 Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 14813[ISI][Medline]
19 Angele MK, Wichmann MW, Ayala A, Cioffi WG, Chaudry IH. Testosterone receptor blockade after hemorrhage in males. Restoration of the depressed immune functions and improved survival following subsequent sepsis. Arch Surg 1997; 132: 120714[Abstract]
20 Leone M, Honstettre A, Lepidi H, et al. Effect of sex on Coxiella burnetii infection: protective role of 17beta-estradiol. J Infect Dis 2004; 189: 33945[CrossRef][ISI][Medline]
21 Osborn TM, Tracy JK, Dunne JR, Pasquale M, Napolitano LM. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med 2004; 32: 223440[ISI][Medline]
22 Mokart D, Capo C, Blache JL, et al. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002; 89: 14506[CrossRef][ISI][Medline]
23 Menger MD, Vollmar B. Systemic inflammatory response syndrome (SIRS) and sepsis in surgical patients. Intensive Care Med 1996; 22: 6167[CrossRef][ISI][Medline]
24 Bochicchio GV, Napolitano LM, Joshi M, et al. Persistent systemic inflammatory response syndrome is predictive of nosocomial infection in trauma. J Trauma 2002; 53: 24550[ISI][Medline]
25 Timsit JF, Fosse JP, Troche G, et al. Calibration and discrimination by daily Logistic Organ Dysfunction scoring comparatively with daily Sequential Organ Failure Assessment scoring for predicting hospital mortality in critically ill patients. Crit Care Med 2002; 30: 200313[CrossRef][ISI][Medline]
26 Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20: 396401[ISI][Medline]
27 Muckart DJ, Bhagwanjee S. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997; 25: 178995[CrossRef][ISI][Medline]
28 Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 136877
29 Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 85873[CrossRef][ISI][Medline]
30 Adrie C, Alberti C, Chaix-Couturier C, et al. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care 2005; 20: 4658[CrossRef][ISI][Medline]
Read all E-letters
E-letters: